Abstract
In summary, more extensive pre-clinical evaluation of SAMMA and other microbicides in development is required. The activity against primary isolates in the presence of genital tract fluids and over a broad pH range should be carefully evaluated. Optimization of formulations will require more attention. Formulation characteristics affecting microbicide efficacy include hydrophilicity, dispersibility, viscosity and bioadhesion. Development and standardization of human explant cultures and animal models to test the efficacy and safety of formulated compounds is essential. Pilot in vivo studies focusing on a thorough investigation of the changes in inflammatory cells and cytokines following topical application of candidate agents are recommended before the initiation of large-scale clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 1099-1102 |
Number of pages | 4 |
Journal | Journal of Antimicrobial Chemotherapy |
Volume | 51 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2003 |
Keywords
- HIV
- Microbicides
ASJC Scopus subject areas
- Pharmacology
- Microbiology (medical)
- Infectious Diseases
- Pharmacology (medical)